SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-04-002160
Filing Date
2004-04-29
Accepted
2004-04-29 13:05:19
Documents
5
Period of Report
2004-04-29
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC b50461tte8vk.htm 8-K 116933
2 EX-1.1 UNDERWRITING AGREEMENT b50461ttexv1w1.txt EX-1.1 103025
3 EX-4.1 SUPPLEMENTAL INDENTURE b50461ttexv4w1.txt EX-4.1 147985
4 EX-5.1 OPINION OF HALE AND DORR LLP b50461ttexv5w1.txt EX-5.1 8696
5 EX-99.1 PRESS RELEASE DATED APRIL 28, 2004 b50461ttexv99w1.txt EX-99.1 3598
  Complete submission text file 0000950135-04-002160.txt   382283
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21481 | Film No.: 04763726
SIC: 2836 Biological Products, (No Diagnostic Substances)